Background: Throughout the COVID-19 pandemic, SARS-CoV-2 genetic variants of concern (VOCs) have repeatedly and independently arisen. VOCs are characterised by increased transmissibility, increased virulence or reduced neutralisation by antibodies obtained from prior infection or vaccination. Tracking the introduction and transmission of VOCs relies on sequencing, typically whole genome sequencing of clinical samples. Wastewater surveillance is increasingly used to track the introduction and spread of SARS-CoV-2 variants through sequencing approaches. Aim: Here, we adapt and apply a rapid, high-throughput method for detection and quantification of the relative frequency of two deletions characteristic of the Alpha, Beta, and Gamma VOCs in wastewater. Methods: We developed drop-off RT-dPCR assays and an associated statistical approach implemented in the R package WWdPCR to analyse temporal dynamics of SARS-CoV-2 signature mutations (spike Δ69–70 and ORF1a Δ3675–3677) in wastewater and quantify transmission fitness advantage of the Alpha VOC. Results: Based on analysis of Zurich wastewater samples, the estimated transmission fitness advantage of SARS-CoV-2 Alpha based on the spike Δ69–70 was 0.34 (95% confidence interval (CI): 0.30–0.39) and based on ORF1a Δ3675–3677 was 0.53 (95% CI: 0.49–0.57), aligning with the transmission fitness advantage of Alpha estimated by clinical sample sequencing in the surrounding canton of 0.49 (95% CI: 0.38–0.61). Conclusion: Digital PCR assays targeting signature mutations in wastewater offer near real-time monitoring of SARS-CoV-2 VOCs and potentially earlier detection and inference on transmission fitness advantage than clinical sequencing.
The COVID-19 pandemic has accelerated the development and adoption of wastewater-based epidemiology. Wastewater samples can provide genomic information for detecting and assessing the spread of SARS-CoV-2 variants in communities and for estimating important epidemiological parameters such as the selection advantage of a viral variant. However, despite demonstrated successes, epidemiological data derived from wastewater suffers from potential biases. Of particular concern are shedding profiles, which can affect the relationship between true viral incidence and viral loads in wastewater. Changes in shedding between variants may decouple the established relationship between wastewater loads and clinical test data. Using mathematical modeling, simulations, and Swiss surveillance data, we demonstrate that estimates of the selection advantage of a variant are not biased by shedding profiles. We show that they are robust to differences in shedding between variants under a wide range of assumptions, and identify specific conditions under which this robustness may break down. Additionally, we demonstrate that differences in shedding only briefly affect estimates of the effective reproduction number. Thus, estimates of selective advantage and reproduction numbers derived from wastewater maintain their advantages over traditional clinical data, even when there are differences in shedding among variants.
Wastewater-based surveillance systems can track trends in multiple pathogens simultaneously by leveraging efficient, streamlined laboratory processing. In Switzerland, wastewater surveillance is conducted for fourteen locations representing 2.3 million people, or 26% of the national population, with simultaneous surveillance of four respiratory pathogens. Trends in respiratory diseases are tracked using a novel, six-plex digital PCR assay targeting Influenza A, Influenza B, Respiratory Syncytial Virus, and SARS-CoV-2 N1 and N2 genes, as well as Murine Hepatitis Virus for recovery efficiency control. The multiplex assay was developed to ensure sensitivity and accurate quantification for all targets simultaneously. Wastewater data is also integrated with disease data obtained through both a mandatory disease reporting system and the Swiss Sentinel System (Sentinella), a voluntary reporting system for general practitioners. Comparisons between wastewater data and case data from July 2023 through July 2024 demonstrate a high level of agreement, specifically for Influenza A, SARS-CoV-2, and Respiratory Syncytial Virus. Lower correspondence is observed for Influenza B, which highlights challenges in tracking disease dynamics during seasons without pronounced outbreak periods. Wastewater monitoring further revealed that targeting the N1 or N2 gene led to divergent estimates of SARS-Cov-2 viral loads, highlighting the impact of mutations in the target region of the assay on tracking trends. The study emphasizes the importance of an integrated wastewater monitoring program as a complementary tool for public health surveillance by demonstrating clear concordance with clinical data for respiratory pathogens beyond SARS-CoV-2.
Safe laboratory processing requires mitigating risks from the release of pathogens into the environment through generated waste streams. This study evaluated the inactivation kinetics of bacteriophage MS2 as a surrogate for infectious viruses in liquid waste produced from total nucleic acid extractions of wastewater. The goal was to determine a waste handling protocol that ensures sufficient viral infectivity loss (i.e., inactivation) for safe disposal. Liquid waste was generated using a viral total nucleic acid extraction kit (Wizard® Enviro Total Nucleic Acid Kit, Promega, The United States of America) containing guanidinium chloride, isopropanol, ethanol, and other residual reagents. MS2 phage was artificially added into liquid waste, and inactivation was monitored over 24 h using double agar layer plaque assays. A one-phase exponential decay model was applied to estimate the time required for safe disposal, showing MS2 inactivation followed an exponential decay pattern, achieving a predicted 6-log10 reduction at an average of 2.41 h (145 min), with a 95 % confidence interval of 1.34 h (80 min) to 4.05 h (243 min). However, only the 24-hour holding time was observed to significantly exceed the 6-log10 reduction threshold, supporting its recommendation as a conservative and practical holding time after which the waste can be safely disposed of as chemical solvent waste without additional decontamination measures such as autoclaving, as viral infectivity is reduced by at least 6-log10.